ClinConnect ClinConnect Logo
Search / Trial NCT05876442

Efficacy of EPSW Plus HILT on Carpal Tunnel Syndrome Post Burn Injury

Launched by CAIRO UNIVERSITY · May 23, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Extracorporeal Shock Wave Therapy High Intensity Laser Therapy Carpal Tunnel Syndrome

ClinConnect Summary

This clinical trial is looking at a new way to treat carpal tunnel syndrome (CTS) that some people develop after suffering burn injuries. The study is testing a combination of two noninvasive treatments: Extracorporeal Shock Wave Therapy (ESWT) and High-Intensity Laser Therapy (HILT). The goal is to see if adding these treatments can help improve symptoms of CTS, which can include pain, numbness, and weakness in the hand and wrist.

To participate in this trial, you must be between 20 to 60 years old and have been diagnosed with carpal tunnel syndrome following a thermal burn injury. You will be assessed using specific tests to confirm your condition. However, people with very severe or mild cases of carpal tunnel syndrome, or those with certain health issues, will not be eligible. If you join the trial, you can expect to receive these treatments in a safe and controlled environment, with close monitoring of your progress. This trial is currently recruiting participants, so if you or someone you know fits the criteria, it might be a good opportunity to explore new treatment options.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients diagnosed with carpal tunnel syndrome after thermal burn injuries.
  • Patients will be diagnosed with median nerve conduction study and Phalen sign and tinel test.
  • Patients age: 20 to 60 years
  • Exclusion Criteria:
  • Patients with severe (absent sensory or motor waves) and mild (sensory nerve latency \>3.5 ms at third digit) CTS according to EMG-NCV study.
  • Conditions that could impact upon or impacted by outcome measures or laser intervention (e.g. hypothyroidism, cancer, active infection, pulmonary disease, acquired immunodeficiency syndrome, associated myopathy, myelopathy, history of neck and/or shoulder surgery, drugabuse, corticosteroids consumption, and pregnancy)
  • Patients received continuous physical therapy or exercise during the previous two weeks or taking analgesic or anti-inflammatory drugs during the week prior to the baseline assessment

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported